Background: Multidrug resistant tuberculosis (MDR‐TB) still continues to be a serious health problem throughout the world. Although main treatment of MDR‐TB is medical, surgical resection with adjuvant medical therapy may increase the chance of cure in selected patients. Methods: We performed surgical resections in 55 patients between 1997 and 2005; 36 were male and 19 were female with a median age of 34 years (range 13 to 66 years). Sputum was negative for 49 patients and positive for 6 patients in the preoperative period. Patients were treated according to a new therapy protocol for a mean of 3.7 months before the operation. Results: Lobectomy was performed in 37 patients, pneumonectomy in 17 patients and lobectomy + segmentectomy in 1 patient. One patient with positive sputum preoperatively died in the early postoperative period (mortality: 1.81 %). Various complications occurred in 16 (29.09 %) patients. Prolonged air leak was the most common complication (n = 8). Bronchopleural fistula (BPF) + empyema occurred in 2 (3.63 %) patients. In the postoperative period, sputum negativity was achieved in all patients except three cases throughout the 57 months of follow-up (cure rate 94.5 %). Patients received drug therapy for 24 months postoperatively. Conclusions: Surgical resection with adjuvant drug therapy increases the chance of cure in patients with localized disease if they have an adequate cardiopulmonary reserve, favorable nutritional status and are treated with a new therapy protocol for at least 3 months.
Key words
MDR‐TB - resection - cure chance
References
1
Pomerantz B J, Cleveland J C, Olson H K, Pomerantz M.
Pulmonary resection for multi-drug resistant tuberculosis.
J Thorac Cardiovasc Surg.
2001;
121
448-453
2
Mohsen T, Zeid A A, Haj-Yahia S.
Lobectomy or pneumonectomy for multidrug-resistant tuberculosis can be performed with acceptable morbidity and mortality: a seven-year review of a single institution's experience.
J Thorac Cardiovasc Surg.
2007;
134
194-198
4
Shiraishi Y, Nakajima J, Katsuragi N, Kurai M, Takahashi N.
Resectional surgery combined chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis.
J Thorac Cardiovasc Surg.
2004;
128
523-528
5
Sung S W, Kang C H, Kim Y T, Han S K, Shim Y S, Kim J H.
Surgery increased chance of cure in multi-drug resistant pulmonary tuberculosis.
Eur J Thorac Cardiothorac Surg.
1999;
16
187-193
6 World Health Organization .Anti-tuberculosis drug resistance in the world. Report no. 3. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1999–2002. Geneva; World Health Organization 2004
7
Leuven M V, De Groot M, Shean K P, Von Oppel U O, Willcox P A.
Pulmonary resection as an adjunct in the treatment of multiple drug-resisitant tuberculosis.
Ann Thorac Surg.
1997;
63
1368-1373
9
Kim Y T, Kim H K, Sung S W, Kim J H.
Long-term outcomes and risk factor analysis pneumonectomy for active and sequela forms of pulmonary tuberculosis.
Eur J Cardiothorac Surg.
2003;
23
833-839
11
Rizzi A, Rocco G, Robustellini M, Rossi G, Pona C D, Massera F.
Results of surgical treatment of tuberculosis. Experience in 206 patients undergoing operation.
Ann Thorac Surg.
1995;
59
896-900
